Naples Prognostic Score for Predicting Postoperative Delirium
ConditionPostoperative Delirium
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorSouth Valley University
About this trial
Naples Prognostic Score (NPS) originally developed to predict outcomes in inflammatory and malignant conditions; we asked if it can effectively predict postoperative delirium (POD) in elderly patients undergoing hip surgery? NPS integrate markers such as albumin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio-all of which have been linked to adverse postoperative outcomes including POD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The elderly age≥60 years
American Society of Anesthesiologists (ASA) classification II∼IV
Patients undergoing hip fracture surgery
Patients who had a complete blood sample were taken preoperatively
Disqualifiers
Patient refused to participate and consent
Patients with a history of mild cognitive impairment (MCI), dementia, and delirium
Ptients with known preoperative infections (pulmonary infection, urinary infection, and sepsis).
Trial population
elderly patients undergoing Hip fracture surgery
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
168 Participants
are grouped into 1 trial groupGroup A: hip group
Trial outcomes
Primary outcomes
1
Assessment of postoperative delirium
Assessment of postoperative deliurim will be done once daily by using an established screening instrument (The Confusion Assessment Method (CAM)). A positive CAM requires both (1) Acute onset \& fluctuating course AND (2) Inattention, plus (3) Disorganized thinking OR (4) Altered level of consciousness.
Time frame
on arrival to PACU, on postoperative day 1, 2, 3, 5, 7.Secondary outcomes
1
Length of hospital stay
Determine the duration of hospital stay for geriatric hip fracture patients in our hospital.
Time frame
Directly before patients' discharge from hospitalSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov